Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
주식 순위 #27019
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
주가
$0.16240909
마지막 동기화: 2025-03-04
시가총액
$35.68M
변동 (1일)
0.27%
변동 (1년)
0.00%
국가
CN
거래 Dali Pharmaceuticalco.,Ltd (603963)

카테고리

Dali Pharmaceuticalco.,Ltd (603963)의 EPS
September 2024 기준 EPS TTM: $-0.02
Dali Pharmaceuticalco.,Ltd의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.02입니다. 2022년 말에는 회사의 EPS가 $-0.01였으며, 이는 2021년의 EPS $-0.03와 감소입니다.
Dali Pharmaceuticalco.,Ltd의 EPS 기록 (2012 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-0.02 57.00%
2023 $-0.01 8.55%
2022 $-0.01 -60.87%
2021 $-0.03 -1,400.00%
2020 0.00 -73.86%
2019 $0.01 31.34%
2018 $0.01 -85.47%
2017 $0.05 -15.72%
2016 $0.05 -22.74%
2015 $0.07 -51.80%
2014 $0.15 6.06%
2013 $0.14 0.44%
2012 $0.14 0.00%
유사 기업 또는 경쟁사의 EPS